TFS CAPITAL LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 197 filers reported holding HAEMONETICS CORP in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
TFS CAPITAL LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2017$1,233,000
+431.5%
30,385
+373.7%
0.40%
+614.3%
Q3 2016$232,000
-77.4%
6,415
-81.9%
0.06%
-70.4%
Q2 2016$1,028,000
-18.5%
35,457
-9.2%
0.19%
+54.9%
Q3 2015$1,262,000
+22.2%
39,048
+56.3%
0.12%
+20.8%
Q2 2015$1,033,000
-67.8%
24,987
-72.5%
0.10%
-60.1%
Q2 2014$3,210,000
+37.2%
90,988
+26.8%
0.25%
+63.2%
Q1 2014$2,339,000
+723.6%
71,780
+908.4%
0.16%
+1092.3%
Q3 2013$284,000
-13.9%
7,118
-10.8%
0.01%
-7.1%
Q2 2013$330,0007,9770.01%
Other shareholders
HAEMONETICS CORP shareholders Q4 2016
NameSharesValueWeighting ↓
Iron Triangle Partners LP 330,000$36,633,0004.66%
BEACONLIGHT CAPITAL, LLC 156,395$17,361,0002.80%
Bridge City Capital, LLC 48,011$5,330,0001.77%
Summit Creek Advisors LLC 121,362$13,472,0001.61%
Sivik Global Healthcare LLC 25,000$2,775,0001.01%
ANCHOR CAPITAL ADVISORS LLC 412,218$45,760,0000.97%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 69,655$7,732,0000.90%
Orbimed Advisors 852,000$94,581,0000.88%
LONDON CO OF VIRGINIA 1,057,738$117,420,0000.67%
WEXFORD CAPITAL LP 40,138$4,456,0000.66%
View complete list of HAEMONETICS CORP shareholders